Form 4: Hims & Hers PAO Becklund Reports RSU Vesting & Tax Withholding

Irene Becklund, Principal Accounting Officer of Hims & Hers Health, Inc., reported the vesting of Restricted Stock Units and subsequent tax-related share disposals.

Summary

• Irene Becklund, Principal Accounting Officer (PAO) of Hims & Hers Health, Inc. (HIMS), reported transactions on March 13, 2026.
• Acquired 17,987 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Disposed of 5,832 shares of Class A Common Stock at a price of $24.77 per share to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Becklund beneficially owns 14,281 shares of Class A Common Stock directly.
• Several tranches of RSUs vested, with varying amounts and remaining balances, all subject to service-based vesting over four-year periods with quarterly installments.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine executive compensation and retention, with no significant positive or negative operational implications for the company.

Positives

• The vesting of Restricted Stock Units indicates continued compensation and retention of a key executive.
• The executive's beneficial ownership of Class A Common Stock remains substantial at 14,281 shares after the transactions.

Negatives

• A portion of the vested shares (5,832 shares) was sold to cover tax obligations, which is a common practice but reduces direct share ownership.

Future Outlook

N/A

Industry Context

StockSavvy.ai notes that routine RSU vesting and tax-related share sales are common compensation events for executives in the healthcare technology sector, reflecting standard equity incentive plans designed for long-term retention.

Comparison to Industry Standards

• StockSavvy.ai observes that the practice of granting Restricted Stock Units with service-based vesting over multi-year periods is a standard compensation mechanism across publicly traded companies, particularly in high-growth sectors like telehealth and digital health.
• Companies such as Teladoc Health (TDOC) and Amwell (AMWL) utilize similar equity compensation structures to align executive incentives with long-term shareholder value and ensure executive retention.
• The tax withholding at vesting is also a standard procedure, consistent with practices seen across the S&P 500.

Related Party Transactions

• The reported transactions are insider dealings between a company officer and the issuer, specifically the vesting of equity awards and subsequent tax-related share disposals.

Stakeholder Impact

• Shareholders: The transactions are routine and reflect standard executive compensation, which is generally factored into investor expectations. The disposal of shares for tax purposes slightly increases the public float but is not material.
• Employees: The vesting of RSUs demonstrates the company's commitment to its equity compensation plans, which can positively influence employee morale and retention, particularly for key executives.

Next Steps

• Continued vesting of remaining Restricted Stock Units according to their respective four-year quarterly schedules.

Key Dates

Recommendation

The filing details routine executive compensation events (RSU vesting and tax-related share sales) and does not provide new information regarding the company's operational performance, financial health, or strategic direction. Therefore, it does not warrant a change in investment recommendation, and a 'hold' stance is maintained based solely on this filing.

Keywords

Hims & Hers Health, HIMS, Irene Becklund, Form 4, SEC filing, insider transaction, RSU vesting, stock compensation, tax withholding, Class A Common Stock